(for preterm infants, newborns, infants, and children)
The full name of this medicinal product is N P, concentrate for solution for infusion, but in the rest of the leaflet, it will be referred to as N P.
N P is a concentrate for solution for infusion, specifically designed for preterm infants, newborns, infants, and children.
It contains five essential trace elements (zinc, copper, manganese, iodine, and selenium) that are considered essential because the body cannot produce them, but they are needed in very small amounts for its proper functioning.
Trace elements are usually provided in a balanced diet.
N P is intended to provide trace elements to preterm infants and newborns, infants, and children who cannot eat normally and need intravenous nutrition.
Before using N P, you should discuss it with your doctor or pharmacist if the child:
During treatment, the doctor will regularly check the levels of trace elements in the blood and adjust the dosage of N P accordingly.
You should tell your doctor about all medicines the child is currently taking or has recently taken, as well as any medicines the child is going to take in the future, including those available without a prescription.
The medicine contains less than 1 mmol (23 mg) of sodium per ampoule, which means the medicine is considered "sodium-free". The medicine contains less than 1 mmol (39 mg) of potassium per ampoule, which means the medicine is considered "potassium-free".
N P will be administered to the child intravenously (into a vein) in the form of an infusion (drip) by a nurse or doctor. They will decide what dose is suitable for the child.
A dose of 1 ml of N P per kg of body weight per day, up to a maximum daily dose of 20 ml, covers the basic requirement for the trace elements contained in the product.
A daily dose of 20 ml of N P should cover the basic requirement for trace elements.
In the case of treating preterm infants, N P should be supplemented with a solution for injection containing only zinc, to achieve a total parenteral zinc intake of 450-500 µg/kg/day.
In the case of long-term (lasting more than 3 weeks) parenteral nutrition of preterm infants, it is recommended to administer a daily infusion containing iron, and to add molybdenum in the case of parenteral nutrition lasting more than 4 weeks.
N P must be diluted before use; it must not be administered to the patient undiluted.
It is very unlikely that a child will receive a larger amount of the medicine in an infusion than they should, because during treatment, they will be monitored by a doctor or nurse. However, if it is suspected that the child has received a larger dose of N P than they should, you should immediately inform the doctor or nurse.
The doctor will stop the administration of N P and perform the necessary laboratory tests in case of suspected overdose.
In case of any further doubts about the use of this medicine, you should consult a doctor or pharmacist.
Like all medicines, N P can cause side effects, although not everybody gets them.
If any of the following symptoms occur, you should immediately inform your doctor:
frequency not known (cannot be estimated from the available data): pain at the injection site.
If any side effects occur, including any side effects not listed in the leaflet, you should inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C,
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of the medicine.
Side effects can be reported directly to the marketing authorization holder.
It has been demonstrated that after dilution, the product retains its chemical and physical stability for 48 hours at a temperature of 25°C.
From a microbiological point of view, the product should be used immediately after dilution. If the product is not used immediately, the user is responsible for the storage time and conditions before use.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after: EXPIRY DATE. The expiry date refers to the last day of the month stated.
Do not freeze.
Do not use this medicine if signs of deterioration are visible.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substances of N P are:
in 10 ml (1 ampoule)
zinc (Zn)
1000 µg
(as zinc gluconate)
copper (Cu)
200 µg
(as copper gluconate)
manganese (Mn)
5 µg
(as manganese gluconate)
iodine (I)
10 µg
(as potassium iodide)
selenuim (Se)
20 µg
(as sodium selenite)
Other ingredients are: hydrochloric acid (to adjust pH) and water for injections.
A clear, colorless concentrate for solution for infusion in 10 ml ampoules, packaged in cardboard boxes of 10 or 50 ampoules.
Not all pack sizes may be marketed.
Laboratoire AGUETTANT
1 rue Alexander Fleming
69007 Lyon
France
Laboratoire AGUETTANT
Lieu-dit Chantecaille
07340 CHAMPAGNE
France
Information intended for healthcare professionals only:
Density 1.0
pH
2.7 to 3.3
Osmolality 15 mosmol/kg
Osmolarity 15 mosmol/l
Do not use the medicinal product N P as a vehicle for other medicines.
Do not mix the medicinal product with other medicinal products, except for sodium chloride 0.9% and glucose 5%.
3 years
It has been demonstrated that after dilution, the product retains its chemical and physical stability for 48 hours at a temperature of 25°C.
From a microbiological point of view, the product should be used immediately after dilution. If the product is not used immediately, the user is responsible for the storage time and conditions before use.
Do not freeze.
Before use, you should ensure that the concentrate for solution for infusion is homogeneous, the ampoule is not damaged, and the solution does not contain solid particles.
The medicinal product N P is not intended for administration in its undiluted form.
The medicinal product N P should be diluted or added to other solutions by gently mixing, under strictly aseptic conditions, immediately before administration in an infusion.
The medicinal product N P should be diluted taking into account the final osmolality of the solution.
For example:
The reconstituted infusion solution should be inspected before use. Only a clear solution without solid particles should be used.
Do not store partially used containers and dispose of all equipment after use.
You should check the compatibility with solutions administered simultaneously through a common cannula.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.